92 results on '"Bellini, M"'
Search Results
2. 3D titania nanotube array support for water electrolysis palladium catalysts
3. A decade of bariatric surgery. What have we learned? Outcome in 520 patients from a single institution
4. Self-perceived normality in defecation habits
5. The general practitioner's approach to irritable bowel syndrome: From intention to practice
6. T.07.6 PATIENTS REFERRED TO ANORECTAL MANOMETRY BEFORE AND DURING THE COVID PANDEMIC: ARE THEY DIFFERENT?
7. T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
8. T.01.1 APPLICATION OF LYON CONSENSUS CRITERIA FOR GERD DIAGNOSIS: EVALUATION OF PATIENTS WITH INCONCLUSIVE DIAGNOSIS AND NEW IMPEDANCE-PH PARAMETERS
9. T.01.6 STRAIGHT LEG RAISE TEST: A NOVEL PROVOCATIVE TEST TO ASSESS ESOPHAGEAL CONTRACTION RESERVE AT HIGH-RESOLUTION MANOMETRY
10. OC.14.2 SINGLE USE DUODENOSCOPE ERCP ON HIGH RISK PATIENTS: SOME REFLECTIONS FROM AN ITALIAN EXPERIENCE
11. OC.11.4 CAN THE LONDON CLASSIFICATION BE USED TO PERFORM AND ANALYZE HIGH DEFINITION 3D ANORECTAL MANOMETRY?
12. OC.11.5 IMPACT OF REFLUX BURDEN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY ACCORDING TO THE CRITERIA PROPOSED BY CCV4.0 COMPARED TO CCV3.0
13. OC.03.3 EOSINOPHILIC ESOPHAGITIS: MOST NON-RESPONDERS TO FIRST COURSE OF PPIS ACHIEVE SUSTAINED HISTOLOGICAL REMISSION FOLLOWING SEQUENTIAL TREATMENT WITH TOPICAL STEROIDS AND SECOND COURSE OF PPIS MONOTHERAPY
14. OC.02.6 BASELINE IL-23 SERUM LEVELS PREDICT MUCOSAL HEALING IN PATIENTS WITH CROHN’S DISEASE TREATED WITH USTEKINUMAB. A PROSPECTIVE STUDY
15. Role of faecal calprotectin as non-invasive marker of intestinal inflammation
16. Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori
17. Gastric emptying in myotonic dystrophic patients
18. AF.44 IG GLYCOSYLATION IN ULCERATIVE COLITIS: IT IS TIME FOR NEW BIOMARKERS
19. AF.77 IRRITABLE BOWEL SYNDROME AND WORK ABILITY IN HEALTH WORKERS EXPOSED TO OCCUPATIONAL STRESS
20. AF.30 RAISING CHILDREN ON A VEGAN DIET: PARENTS’ DECISIONS AND RELATIONSHIP WITH PEDIATRICIANS AND SOCIETY
21. AF.2 A NATIONAL SURVEY OF UPPER GASTROINTESTINAL SYMPTOMS IN PATIENTS ATTENDING GASTROENTEROLOGY CLINICS OF THE ITALIAN NHS: AN INTERIM ANALYSIS OF THE GUESS STUDY
22. AF.3 QUALITY OF LIFE IN PATIENTS COMPLAINING OF UPPER GASTROINTESTINAL SYMPTOMS: A NATIONAL SURVEY IN PATIENTS ATTENDING GASTROENTEROLOGY CLINICS OF THE ITALIAN NHS: AN INTERIM ANALYSIS OF THE GUESS STUDY
23. OC.01.10 EGJ OUTFLOW OBSTRUCTION ACCORDING TO THE NEW CHICAGO CLASSIFICATION: HOW MANY DIAGNOSES MIGHT BE CONFIRMED?
24. T05.02.7 DYNAMIC TRANSPERINEAL ULTRASONOGRAPHY FOR DEFECATION DISORDERS: READY TO USE?
25. T05.02.4 BILE ACID MALABSORPTION: AN OVERLOOKED DIAGNOSIS?
26. T01.02.10 PROVOCATIVE TESTS DURING HIGH-RESOLUTION MANOMETRY MAY BE HELPFUL TO DISTINGUISH PATIENTS WITH EOSINOPHILIC ESOPHAGITIS RESPONDING TO PPI THERAPY
27. T01.02.11 WHICH CORRELATION BETWEEN OCULAR SURFACE DISEASE AND GERD? A PILOT STUDY
28. OC.02.6 THE SERUM TRIIODOTHYRONINE TO THYROXINE (T3/T4) RATIO IS ABLE TO PREDICT THERAPEUTIC OUTCOME IN ELDERLY IBD PATIENTS
29. OC.03.4 ESOPHAGO-GASTRIC JUNCTION CONTRACTILE INTEGRAL (EGJ-CI) MAY PREDICT RESPONSE TO TREATMENT IN PATIENTS WITH ESOPHAGEAL ACHALASIA
30. P.06.9 TWO NEW PROGNOSTIC MARKERS OF MUCOSAL HEALING IN PATIENTS TREATED WITH ANTI-TNF FOR ULCERATIVE COLITIS: THE NEUTROPHIL-TO-LYMPHOCYTE-RATIO AND THE PLATELET-TO-LYMPHOCYTE-RATIO
31. P.02.6 LOW FODMAP DIET IN THE LONG TERM: EFFICACY, ACCEPTABILITY AND INDIVIDUAL PERCEPTION OF TRIGGER FOODS. A PILOT STUDY
32. P.01.8 PROVOCATIVE TESTS DURING HIGH-RESOLUTION MANOMETRY MAY BE HELPFUL TO DISTINGUISH PATIENTS WITH EOSINOPHILIC ESOPHAGITIS RESPONDING TO PPI THERAPY
33. P.01.2 ESOPHAGO-GASTRIC JUNCTION CONTRACTILE INTEGRAL (EGJ-CI) MAY PREDICT RESPONSE TO TREATMENT IN PATIENTS WITH ESOPHAGEAL ACHALASIA
34. OC.09.4 FECAL CALPROTECTIN COULD PREDICT MUCOSAL HEALING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH VEDOLIZUMAB: A PROSPECTIVE SINGLE-CENTER STUDY
35. OC.05.3 HISTOMORPHOLOGICAL AND MOLECULAR CHARACTERIZATION OF PARKINSON'S DISEASE PATIENTS WITH CONSTIPATION: A PILOT STUDY
36. P.08.24 EUS-FNA WET-TECHNIQUE IN 31 SOLID PANCREATIC LESIONS: PISA EXPERIENCE
37. P.07.6 LOW-FODMAPS DIET IMPROVES INTESTINAL SYMPTOMS IN IBD PATIENTS WITH DISEASE REMISSION: RANDOMIZED CASE-CONTROL STUDY
38. P.06.9 MULTIPLE RAPID SWALLOW MIGHT BE HELPFUL TO IMPROVE THE DIAGNOSIS OF INEFFECTIVE ESOPHAGEAL MOTILITY
39. P.04.5 IPMN RETROSPECTIVE RESULTS IN PATIENTS REFERRED TO A MULTIDISCIPLINARY PANCREATIC GROUP
40. OC.06.5 LOW-FODMAP DIET RESULTED EFFECTIVE IN REDUCING SYMPTOM PERCEPTION IN PATIENTS WITH FUNCTIONAL HEARTBURN: RANDOMIZED, CROSS-OVER CONTROLLED STUDY
41. OC.10.6 FECAL CALPROTECTIN PREDICTS MUCOSAL HEALING IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH ADALIMUMAB OR GOLIMUMAB. A PROSPECTIVE SINGLE-CENTRE STUDY
42. OC.09.3 DYSPHAGIA IS A DRIVEN SYMPTOM ABLE TO PREDICT PERSISTENT EGJ-OUTFLOW OBSTRUCTION DURING A SIX-MONTH FOLLOW-UP: HRM STUDY WITH PROVOCATIVE TEST
43. OC.03.6 AN ADAPTED LOW FODMAP DIET IS SAFE AND EFFECTIVE ALSO IN THE LONG TERM
44. P.11.9: Mucosal and Transmural Healing During Anti-Tnf Therapy. Is Fecal Calprotectin a Marker of Therapeutic Response?
45. P.01.12: The Abdominal Length of Lower Esophageal Sphincter is Inversely Correlated with Abnormal Esophageal Acid Exposure
46. OC.15.4: High Resolution Manometry Should be Considered the best Test to Diagnose Sliding Hiatal Hernia
47. OC.15.1: High-Volume Rapid Drinking test Better Distinguishes Esophageal Body Inhibition Compared to Low-Volume Multiple Rapid Swallows
48. OC.03.3: Low Fodmaps Diet is Safe and Effective, but Patients’ Perception is not Always the Reality!
49. P.14.8 DO ULCERATIVE COLITIS PATIENTS TREATED WITH CORTICOSTEROIDS AT DIAGNOSIS REALLY HAVE A MORE AGGRESSIVE DISEASE COURSE?
50. P.13.13 DYNAMIC TRANSPERINEAL ULTRASOUND FOR THE EVALUATION OF PELVIC FLOOR DISORDERS: WHICH IS THE BEST POSITION?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.